Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929729 · ClinicalTrials.gov registry record · Phase 4
Iron Deficiency Anemia (IDA) and the Brain
A Phase 4 study of Anemia and Iron Deficiency Anemia, sponsored by Children's Hospital Los Angeles.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 4
- Study locations
NCT05929729 is a Phase 4 study of Anemia and Iron Deficiency Anemia that is actively recruiting participants, run by Children's Hospital Los Angeles. The registered enrollment target is 120 participants, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (72% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT05929729, a Phase 4 study of Anemia and Iron Deficiency Anemia, is actively recruiting participants, sponsored by Children's Hospital Los Angeles.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a trial with an observational and an interventional arm, in patients with moderate to severe anemia and control subjects. The main purposes of this study is to phenotype the scope of neurocognitive deficits from iron deficiency anemia (IDA) in adult women, determine derangements in cerebral perfusion, vascular reactivity, functional connectivity, and blood brain barrier permeability in adult-onset IDA and relate them to neurocognitive deficits, as well as determine the reversibility and durability of both the physiologic and neurocognitive derangements by iron replacement therapy. All eligible subjects will be asked to provide informed consent before participating in the study.
Conditions Studied
Interventions
- DRUG Ferric derisomaltose
- DRUG NovaFerrum
Study Locations (4)
California
- City of Hope Blood Donor Center - Duarte
- Cedar Sinai Blood Bank - Los Angeles
- Children's Hospital Los Angeles - Los Angeles
- University of California, Los Angeles Blood Donor Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-12-07 |
| Est. Completion | 2028-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05929729
The ClinicalTrials.gov registry entry for NCT05929729 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (72% lower). The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which Ferric derisomaltose is the first listed.
NCT05929729 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05929729 about?
NCT05929729 is a clinical study titled "Iron Deficiency Anemia (IDA) and the Brain". This is a trial with an observational and an interventional arm, in patients with moderate to severe anemia and control subjects. The main purposes of this study is to phenotype the scope of neurocognitive deficits from iron deficiency anemia (IDA) in adult women, determine derangements in cerebral ...
What is the current status of trial NCT05929729?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2023-12-07. Estimated completion is 2028-09-01.
What conditions does trial NCT05929729 study?
This clinical trial studies the following conditions: Anemia, Iron Deficiency Anemia, Anemia, Iron Deficiency, IDA - Iron Deficiency Anemia.
What interventions are being tested in trial NCT05929729?
The interventions under investigation include: Ferric derisomaltose (DRUG), NovaFerrum (DRUG).
Who is sponsoring clinical trial NCT05929729?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929729 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETED · Phase 4
-
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
COMPLETED · Phase 4
-
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
COMPLETED · Phase 4
-
IV Iron Safety: Evaluation of Iron Species in Healthy Subjects
COMPLETED · Phase 4
-
Prevention of Iron Deficiency in Breastfed Infants
COMPLETED · Phase 4
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.